U.S. Communications Stock News

Neurocrine Biosciences recently strengthened its rare disease position by completing the Soleno Therapeutics acquisition and preparing to present new two-year CRENESSITY data in classic congenital adrenal hyperplasia at ENDO 2026 in Chicago, highlighting long-term androgen control and reduced glucocorticoid exposure in adult and pediatric patients. These developments underscore how Neurocrine is building a broader endocrine and neurology franchise that could influence physician behavior,...

Healthpeak Properties (NYSE:DOC) completed the IPO of its Janus Living platform, generating significant proceeds while keeping majority ownership. Following a strong first quarter, the company raised its 2026 FFOA guidance. These moves mark a material shift in Healthpeak Properties' portfolio mix and capital position compared with prior updates that focused on valuation and stock performance. Healthpeak Properties centers its business on healthcare real estate, which sits at the...

DocuSign (NasdaqGS:DOCU) has launched an Intelligent Agreement Management app, powered by its Iris AI, within OpenAI's ChatGPT and Codex platforms. The company has also appointed Graham Sheldon, a former product leader at UiPath and Microsoft, as its new Chief Product Officer. For investors watching how software providers use AI in real business workflows, DocuSign sits at an interesting crossroads of e-signatures, contract lifecycle tools and broader agreement management. Its new Iris AI...

Recent performance snapshot for SoFi Technologies (SOFI) SoFi Technologies (SOFI) has drawn fresh attention after recent trading left the stock at $17.15, with returns mixed across timeframes, including a gain over the past month but a decline over the past 3 months. See our latest analysis for SoFi Technologies. Recent gains, including a 7.05% 1 month share price return, come against a weaker backdrop. The year to date share price is down 37.55%, even as the 3 year total shareholder return...

In recent days, GE Aerospace, the aviation-focused successor of General Electric, reported strong first-quarter 2026 results, lifted its full-year guidance, and secured major new commercial and defense engine orders, including a substantial jump in demand for its LEAP, GEnx, and GE9X models. Airlines such as British Airways and Air New Zealand opting for GE’s GEnx engines over competing offerings, combined with a growing services backlog and a new U.S. Air Force engine development contract,...

Recent performance snapshot Carpenter Technology (CRS) has drawn attention after a strong price move, with the stock showing gains over the past week, month, past 3 months and year, backed by positive annual revenue and net income figures. See our latest analysis for Carpenter Technology. At a latest share price of $492.62, Carpenter Technology’s recent momentum is strong, with a 27.26% 3 month share price return and a very large 3 year total shareholder return that reflects a major rerating...

Minerals Technologies stock update Minerals Technologies (MTX) has been drawing attention after recent share price moves, with the stock last closing at $76.70. Investors are weighing this level against the company’s current fundamentals and recent return profile. See our latest analysis for Minerals Technologies. The latest 1 day share price return of 2.21% comes after a softer 30 day share price return of 2.91%. The 90 day share price return of 13.85% and 1 year total shareholder return of...

Matador Resources stock performance snapshot Matador Resources (MTDR) has attracted attention after recent trading, with the stock closing at US$55.75 and showing mixed short term moves, up over the past week but down over the past month. Over longer periods, Matador Resources has delivered total returns of 28.4% over the past year and 15.4% over the past 3 months, with year to date performance of 28.6%. See our latest analysis for Matador Resources. The share price has pulled back over the...

MACOM Technology Solutions Holdings (MTSI) has renewed attention on its stock after announcing new RF and optical components for direct to device SATCOM payloads, aimed at next generation satellite communication systems. See our latest analysis for MACOM Technology Solutions Holdings. The recent SATCOM product announcements come after a sharp run in the stock, with an 84.44% 3 month share price return and a very large 5 year total shareholder return, although the shares have slipped around 2%...

Earlier this week, Sherwin-Williams announced its 2026 “Loneliest Color” selection, Offbeat Green SW 6706, a vivid citric lime green highlighted through cultural collaborations and limited-edition products that bring the shade into everyday experiences. By spotlighting its least tinted shade each year, the company is using an unconventional marketing platform to link brand identity with individuality and emotionally driven design choices in the home. We’ll now examine how UBS’s downgrade,...

If you are wondering whether Corteva at around US$77 a share still offers value or is starting to look stretched, the next few sections will help you frame that question clearly. The stock has pulled back recently, with returns down 3.9% over the past week and down 7.7% over the past month, although it remains up 14.3% year to date and 9.8% over the past year. Recent headlines around Corteva have focused on its position within the wider materials sector and how investors are reassessing risk...

AM Best recently affirmed the A- (Excellent) Financial Strength Rating and the "a-" Long-Term Issuer Credit Rating of North End Re Ltd. (Bermuda), a subsidiary of Brookfield Wealth Solutions, maintaining a stable outlook based on its strong balance sheet, adequate operating performance, and support from its parent. A key element of this rating affirmation is AM Best’s recognition of North End Re Ltd.’s plans to assume annuity-type business from European and Asian markets, highlighting the...

Zions Bancorporation National Association (NasdaqGS:ZION) has appointed Daniel J. Ryan, a retired PwC partner, to its board of directors. Ryan brings more than 40 years of experience in public banking, governance, risk, and cybersecurity oversight. His appointment expands the board and includes immediate roles on key governance, audit, and risk related committees. Zions Bancorporation, a regional banking company, operates in a sector where regulators and investors pay close attention to...

Oruka Therapeutics (ORKA) stock is drawing fresh attention after positive interim Phase 2a data for lead antibody ORKA-001 in moderate to severe plaque psoriasis, as well as an expanded IL-23 license that now clearly covers inflammatory bowel disease. See our latest analysis for Oruka Therapeutics. The latest data and licensing news come after a sharp move in the share price, with a 1-day share price return of 8.88% and a 7-day share price return of 7.42%. However, the 30-day share price...

Flex (NasdaqGS:FLEX) has completed its acquisition of Electrical Power Products (EP²). The company has also finalized plans to separate its Power and Cloud business into a new entity, often referred to as SpinCo. These moves expand Flex's reach in grid modernization, customized power control, utility markets, and AI data center infrastructure. The EP² deal is described as accretive to earnings, and the related credit agreement is now closed. For investors watching electrification and AI...

Recent performance context Clover Health Investments (CLOV) has drawn attention after a sharp share price move, with the stock closing at US$3.99. Investors are considering this in light of its recent returns and its ongoing Medicare Advantage focused business. See our latest analysis for Clover Health Investments. The latest 1 day share price return of 9.32% comes after a softer 7 day share price return of 4.55%. However, the 30 day share price return of 52.87% and 90 day share price return...

Olaplex Holdings (NasdaqGS:OLPX) has reached a court approved settlement in consolidated shareholder derivative litigation. The settlement requires corporate governance reforms and the withdrawal of related legal claims. Insurers are set to cover agreed legal fees as part of the settlement terms. The court has granted preliminary approval. The settlement marks a key moment for the company’s risk profile and oversight framework. Olaplex Holdings, known for its professional and consumer hair...

Viking Therapeutics (VKTX) is back in focus as investors track upcoming clinical catalysts for its obesity drug VK2735, including Phase 1 maintenance trial results in Q3 2026 that could influence expectations for the stock. See our latest analysis for Viking Therapeutics. Recent excitement around VK2735 has not prevented some cooling in the stock, with the share price down 16% year to date and the 90 day share price return also weaker, even as the 1 year and 5 year total shareholder returns...

Lamar Advertising recently reported that outdoor advertising demand remains healthy, with local markets solid and national advertisers returning, while digital billboards now make up nearly one-third of billboard billings and enhance its ability to flex ad inventory. Management’s decision to keep full-year AFFO guidance intact, coupled with the possibility of a dividend increase if trends persist, signals confidence in the cash-generating strength of its expanding digital footprint. Next,...

Wondering whether Gartner at around US$164.87 offers value or just more volatility? This article walks through what the current price really implies for you as a shareholder or potential buyer. The stock has risen 2.3% over the past week and 10.3% over the past month, yet remains down 30.4% year to date and has fallen 60.9% over the past year. This raises questions about how the market is reassessing its growth prospects and risk profile. Recent coverage has focused on how market sentiment...

Zymeworks recently reported positive updates across its oncology portfolio, including encouraging Phase 1 data for ZW191, advancement of its pan‑RAS ADC platform, and regulatory progress for zanatumab with a US PDUFA date set for August 25, 2026 and a supplemental BLA filing in China that triggered milestone payments from Jazz Pharmaceuticals and BeiGene. These clinical and regulatory advances, alongside a new US$125,000,000 share repurchase authorization and continued interest from global...

GE HealthCare Technologies (NasdaqGS:GEHC) received FDA clearance for its MIM Contour ProtégéAI+ 2.0 software. The AI enabled tool is designed to support more automated and precise radiation therapy planning for cancer patients. The clearance includes a Predetermined Change Control Plan that allows future AI features to be deployed more quickly. For investors watching GE HealthCare's oncology and imaging efforts, this update adds another piece to the broader medical technology story. The...

Zhihu (NYSE:ZH) reported Q1 2026 revenue of C¥651.6 million, with a basic EPS loss of C¥0.11 and a quarterly net income loss of C¥8.5 million. Over the trailing twelve months, revenue totaled C¥2.7 billion and the EPS loss stood at C¥2.42. The company has seen quarterly revenue move between C¥643.5 million and C¥859.2 million since Q4 2024, with basic EPS shifting from a profit of C¥1.01 in Q4 2024 to a loss of C¥2.66 in Q4 2025, followed by the latest quarter’s narrower loss. As a result,...

How W. R. Berkley’s recent performance looks in context W. R. Berkley (WRB) stock has delivered mixed returns recently, with a gain over the past week but declines over the past month and past 3 months, leaving the year to date performance in negative territory. Over a longer horizon, the stock shows a very different picture, with multi year total returns over the past 3 and 5 years that are well ahead of the recent shorter term pullback. This contrast may catch your eye if you track...